{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:18:28Z","timestamp":1788787108078,"version":"build-2803163510"},"reference-count":78,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2022.0122","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T06:46:23Z","timestamp":1655189183000},"source":"Crossref","is-referenced-by-count":25,"title":["Substance-use disorders in children and adolescents"],"prefix":"10.3238","author":[{"given":"Rainer","family":"Thomasius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Paschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Arnaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"10.3238\/arztebl.m2022.0122_ref1","doi-asserted-by":"crossref","unstructured":"Mokdad AH, Forouzanfar MH, Daoud F, et al.: Global burden of diseases, injuries, and risk factors for young people\u2019s health during 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2016; 387: 2383\u2013401.","DOI":"10.1016\/S0140-6736(16)00648-6"},{"key":"10.3238\/arztebl.m2022.0122_ref2","doi-asserted-by":"crossref","unstructured":"Gore FM, Bloem PJ, Patton GC, et al.: Global burden of disease in young people aged 10\u201324 years: a systematic analysis. Lancet 2011; 377: 2093\u2013102.","DOI":"10.1016\/S0140-6736(11)60512-6"},{"key":"10.3238\/arztebl.m2022.0122_ref3","unstructured":"Orth B, Merkel C: Die Drogenaffinit\u00e4t Jugendlicher in der Bundesrepublik Deutschland 2019. Rauchen, Alkoholkonsum und Konsum illegaler Drogen: aktuelle Verbreitung und Trends. BZgA-Forschungsbericht. K\u00f6ln: Bundeszentrale f\u00fcr gesundheitliche Aufkl\u00e4rung 2020. www.bzga.de\/fileadmin\/user_upload\/PDF\/studien\/Drogenaffinitaet_Jugendlicher_2019_Basisbericht.pdf (last accessed on 10 May 2021)."},{"key":"10.3238\/arztebl.m2022.0122_ref4","doi-asserted-by":"crossref","unstructured":"Arnaud N, Thomasius R: Substanzmissbrauch und Abh\u00e4ngigkeit bei Kindern und Jugendlichen. 1. Auflage. Stuttgart: Kohlhammer 2019.","DOI":"10.1007\/978-3-642-54671-6_287-2"},{"key":"10.3238\/arztebl.m2022.0122_ref5","unstructured":"Zeiher J, Lange C, Starker A, Lampert T, Kuntz B: Tabak- und Alkoholkonsum bei 11- bis 17-J\u00e4hrigen in Deutschland \u2013 Querschnittergebnisse aus KiGGS Welle 2 und Trends. Journal of Health Monitoring 2018; 2: 23\u201344. edoc.rki.de\/bitstream\/handle\/176904\/5690\/JoHM_02_2018_Tabak_Alkoholkonsum_KiGGS-Welle2. pdf?sequence=1&isAllowed=y (last accessed on 10 May 2021)."},{"key":"10.3238\/arztebl.m2022.0122_ref6","doi-asserted-by":"crossref","unstructured":"Kessler RC, Avenevoli S, Costello EJ, et al.: Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry 2012; 69: 372\u201380.","DOI":"10.1001\/archgenpsychiatry.2011.160"},{"key":"10.3238\/arztebl.m2022.0122_ref7","doi-asserted-by":"crossref","unstructured":"Plener PL, Straub J, Fegert JM, Keller F: Behandlung psychischer Erkrankungen von Kindern in deutschen Krankenh\u00e4usern: Analyse der H\u00e4ufigkeiten der Jahre 2003 bis 2012. Nervenheilkunde 2015; 34: 18\u201323.","DOI":"10.1055\/s-0038-1627551"},{"key":"10.3238\/arztebl.m2022.0122_ref8","doi-asserted-by":"crossref","unstructured":"Moffitt TE: Adolescence-limited and life-course-persistent antisocial behavior: a developmental taxonomy. Psychol Rev 1993; 100: 674\u201301.","DOI":"10.1037\/0033-295X.100.4.674"},{"key":"10.3238\/arztebl.m2022.0122_ref9","doi-asserted-by":"crossref","unstructured":"Levy S, Vaughn BL, Knight JR: Office-based intervention for adolescent substance abuse. Pediatr Clin North Am 2002; 49: 329\u201343.","DOI":"10.1016\/S0031-3955(01)00007-4"},{"key":"10.3238\/arztebl.m2022.0122_ref10","doi-asserted-by":"crossref","unstructured":"Champion HLO, Foley KL, DuRant RH: Adolescent sexual victimization, use of alcohol and other substances, and other health risk behaviors. J Adolesc Health 2004; 35: 321\u201328.","DOI":"10.1016\/S1054-139X(04)00099-0"},{"key":"10.3238\/arztebl.m2022.0122_ref11","unstructured":"Weichold K, B\u00fchler A, Silbereisen RK: Konsum von Alkohol und illegalen Drogen im Jugendalter. In: Silbereisen RK, Hasselhorn M (eds.): Enzyklop\u00e4die der Psychologie: Themenbereich C Theorie und Forschung, Serie V Entwicklungspsychologie, Band 5. Entwicklungspsychologie des Jugendalters. G\u00f6ttingen: Hogrefe 2008; 537\u201386."},{"key":"10.3238\/arztebl.m2022.0122_ref12","doi-asserted-by":"crossref","unstructured":"Grant BF, Goldstein RB, Saha TD, et al.: Epidemiology of DSM-5 alcohol use disorder: results from the national epidemiologic survey on alcohol and related conditions III. JAMA Psychiatry 2015; 72: 757\u201366.","DOI":"10.1001\/jamapsychiatry.2015.0584"},{"key":"10.3238\/arztebl.m2022.0122_ref13","doi-asserted-by":"crossref","unstructured":"Y\u00fccel M, Lubman DI: Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention. Drug Alcohol Rev 2007; 26: 33\u20139.","DOI":"10.1080\/09595230601036978"},{"key":"10.3238\/arztebl.m2022.0122_ref14","doi-asserted-by":"crossref","unstructured":"Lees B, Meredith LR, Kirkland AE, Bryant BE, Squeglia LM: Effect of alcohol use on the adolescent brain and behavior. Pharmacol Biochem Behav 2020; 192: 172906.","DOI":"10.1016\/j.pbb.2020.172906"},{"key":"10.3238\/arztebl.m2022.0122_ref15","doi-asserted-by":"crossref","unstructured":"Volkow ND, Baler RD, Compton WM, Weiss SR: Adverse health effects of marijuana use. N Engl J Med 2014; 370: 2219\u201327.","DOI":"10.1056\/NEJMra1402309"},{"key":"10.3238\/arztebl.m2022.0122_ref16","doi-asserted-by":"crossref","unstructured":"Tomas-Roig J, Benito E, Agis-Balboa RC, et al.: Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult mice. Addict Biol 2016; 22: 1778\u201389.","DOI":"10.1111\/adb.12446"},{"key":"10.3238\/arztebl.m2022.0122_ref17","unstructured":"Friemel CM, Schneider M, Lutz B, et al.: Kognition. In: Hoch E, Friemel CM, Schneider M (eds.): Cannabis: Potenzial und Risiko. Eine wissenschaftliche Bestandsaufnahme. Heidelberg: Springer Nature, 2019: 66\u201395."},{"key":"10.3238\/arztebl.m2022.0122_ref18","doi-asserted-by":"crossref","unstructured":"Ganzer F, Br\u00f6ning S, Kraft S, Sack PM, Thomasius R: Weighing the evidence: a systematic review on long-term neurocognitive effects of cannabis use in abstinent adolescents and adults. Neuropsychol Rev 2016; 26: 186\u201322.","DOI":"10.1007\/s11065-016-9316-2"},{"key":"10.3238\/arztebl.m2022.0122_ref19","doi-asserted-by":"crossref","unstructured":"Hoch E, von Keller R, Schmieder S, et al.: Affektive St\u00f6rungen und Angstst\u00f6rungen. In: Hoch E, Friemel CM, Schneider M (eds.): Cannabis: Potenzial und Risiko. Eine wissenschaftliche Bestandsaufnahme. Heidelberg: Springer Nature 2019: 213\u201332.","DOI":"10.1007\/978-3-662-57291-7"},{"key":"10.3238\/arztebl.m2022.0122_ref20","doi-asserted-by":"crossref","unstructured":"Hasan A, von Keller R, Friemel CM, et al.: Cannabis use and psychosis: a review of reviews. Eur Arch Psychiatry Clin Neurosci 2020; 270: 403\u201312.","DOI":"10.1007\/s00406-019-01068-z"},{"key":"10.3238\/arztebl.m2022.0122_ref21","doi-asserted-by":"crossref","unstructured":"Hindley G, Beck K, Borgan F, et al.: Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. Lancet Psychiatry 2020; 7: 344\u201353.","DOI":"10.1016\/S2215-0366(20)30074-2"},{"key":"10.3238\/arztebl.m2022.0122_ref22","doi-asserted-by":"crossref","unstructured":"Macleod J, Oakes R, Copello A, et al.: Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 2004; 363: 1579\u201388.","DOI":"10.1016\/S0140-6736(04)16200-4"},{"key":"10.3238\/arztebl.m2022.0122_ref23","doi-asserted-by":"crossref","unstructured":"Petraitis J, Flay BR, Miller TQ: Illicit substance use among adolescents: a matrix of prospective factors. Subst Use Misuse 1998; 33: 2561\u2013604.","DOI":"10.3109\/10826089809059341"},{"key":"10.3238\/arztebl.m2022.0122_ref24","doi-asserted-by":"crossref","unstructured":"Jurk S, Kuitunen-Paul S, Kroemer NB, et al.: IMAGEN consortium. Personality and substance use: psychometric evaluation and validation of the Substance Use Risk Profile Scale (SURPS) in English, Irish, French, and German adolescents. Alcohol Clin Exp Res. 2015; 39: 2234\u201348.","DOI":"10.1111\/acer.12886"},{"key":"10.3238\/arztebl.m2022.0122_ref25","doi-asserted-by":"crossref","unstructured":"Conway KP, Swendsen J, Husky MM, He JP, Merikangas KR: Association of lifetime mental disorders and subsequent alcohol and illicit drug use: results from the National Comorbidity Survey-Adolescent Supplement. J Am Acad Child Adolesc Psychiatry 2016; 55: 280\u20138.","DOI":"10.1016\/j.jaac.2016.01.006"},{"key":"10.3238\/arztebl.m2022.0122_ref26","unstructured":"\u00d6zgen H, Spijkerman R, Noack M: International consensus statement for the screening, diagnosis, and treatment of adolescents with concurrent attention-deficit\/hyperactivity disorder and substance use disorder. Eur Addict Res 2020; 26: 223\u201332."},{"key":"10.3238\/arztebl.m2022.0122_ref27","doi-asserted-by":"crossref","unstructured":"Kandel DB, Johnson JG, Bird HR, et al.: Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA Study. J Acad Child Adolesc Psychiatry 1999; 38: 693\u20139.","DOI":"10.1097\/00004583-199906000-00016"},{"key":"10.3238\/arztebl.m2022.0122_ref28","doi-asserted-by":"crossref","unstructured":"Arnaud N, Thomasius R: St\u00f6rungen durch Substanzgebrauch und abh\u00e4ngige Verhaltensweisen in der ICD-11. Z Kinder Jugendpsychiatr Psychother 2021; 49: 486\u201393.","DOI":"10.1024\/1422-4917\/a000748"},{"key":"10.3238\/arztebl.m2022.0122_ref29","doi-asserted-by":"crossref","unstructured":"Thomasius R, Arnaud N, Holtmann M, Kiefer F: Substanzbezogene St\u00f6rungen im Jugend- und jungen Erwachsenenalter. Z Kinder Jugendpsychiatr Psychother 2020; 48: 448\u201352.","DOI":"10.1024\/1422-4917\/a000725"},{"key":"10.3238\/arztebl.m2022.0122_ref30","doi-asserted-by":"crossref","unstructured":"Thomasius R, Sack PM, Arnaud N, Hoch E: Behandlung alkoholbezogener St\u00f6rungen bei Kindern und Jugendlichen: Altersspezifische Empfehlungen der neuen interdisziplin\u00e4ren S3-Leitlinie. Z Kinder Jugendpsychiatr Psychother 2016; 44: 295\u201305.","DOI":"10.1024\/1422-4917\/a000435"},{"key":"10.3238\/arztebl.m2022.0122_ref31","doi-asserted-by":"crossref","unstructured":"Thomasius R, Thoms E, Melchers P, et al.: Anforderungen an die qualifizierte Entzugsbehandlung bei Kindern und Jugendlichen. Sucht 2016; 62: 107\u201311.","DOI":"10.1024\/0939-5911\/a000416"},{"key":"10.3238\/arztebl.m2022.0122_ref32","doi-asserted-by":"crossref","unstructured":"Holtmann M, Thomasius R, Melchers P, Klein M, Schimansky G, Krt\u00f6mer T, Reis O: Anforderungen an die station\u00e4re medizinische Rehabilitation f\u00fcr Jugendliche mit substanzbedingten Erkrankungen. Z Kinder Jugendpsychiatr Psychother 2016; 46: 173\u201381.","DOI":"10.1024\/1422-4917\/a000573"},{"key":"10.3238\/arztebl.m2022.0122_ref33","doi-asserted-by":"crossref","unstructured":"AACAP Official Action Bukstein OG, Bernet W, Arnold V, et al.: Practice parameter for the assessment and treatment of children and adolescents with substance use disorder. J Am Acad Child Adolesc Psychiatry 2005; 44: 609\u2013621.","DOI":"10.1097\/01.chi.0000159135.33706.37"},{"key":"10.3238\/arztebl.m2022.0122_ref34","doi-asserted-by":"crossref","unstructured":"Gates PJ, Sabioni P, Copeland J, Le Foll B, Gowing L: Psychosocial interventions for cannabis use disorder. Cochrane Database Syst Rev 2016; 5: CD005336.","DOI":"10.1002\/14651858.CD005336.pub4"},{"key":"10.3238\/arztebl.m2022.0122_ref35","unstructured":"Wagner EF, Tarolla SM: Course and outcome. In: Essau CA (eds.): Substance abuse and dependence in adolescence. Hove UK: Brunner-Routledge 2002; 119\u201342."},{"key":"10.3238\/arztebl.m2022.0122_ref36","doi-asserted-by":"crossref","unstructured":"Hoch E, Noack R, Henker J, et al.: Efficacy of a targeted cognitive-behavioral treatment program for cannabis use disorders (CANDIS). Eur Neuropsychopharmacol 2012; 22: 267\u201380.","DOI":"10.1016\/j.euroneuro.2011.07.014"},{"key":"10.3238\/arztebl.m2022.0122_ref37","doi-asserted-by":"crossref","unstructured":"Romanos M, Fegert JM, Roessner V, Schulte-K\u00f6rne G, Banaschewski T: Zur Rolle und Bedeutung der Kinder- und Jugendpsychiatrie, -psychosomatik und -psychotherapie (KJPPP) in den geplanten nationalen Gesundheitszentren. Z Kinder Jugendpsychiatr und Psychother 2019; 47: 103\u201310.","DOI":"10.1024\/1422-4917\/a000649"},{"key":"10.3238\/arztebl.m2022.0122_ref38","doi-asserted-by":"crossref","unstructured":"Hoch E, Bonnet U, Thomasius R, Ganzer F, Havemann-Reinecke U, Preuss UW: Risks associated with the non-medicinal use of cannabis. Dtsch Arztebl Int 2015; 112: 271\u20138.","DOI":"10.3238\/arztebl.2015.0271"},{"key":"10.3238\/arztebl.m2022.0122_ref39","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20\u201307\u201301\u2013001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration 2020. www.samhsa.gov\/data\/ (last accessed on 23 April 2021)."},{"key":"10.3238\/arztebl.m2022.0122_ref40","unstructured":"Daubner H, Specht S, K\u00fcnzel J, Pfeiffer-Gerschel T, Braun B: Jahresstatistik 2018 der professionellen Suchthilfe. In: Deutsche Hauptstelle f\u00fcr Suchtfragen (eds.): DHS Jahrbuch 2020. Lengerich: Pabst 2020: 179\u2013205."},{"key":"10.3238\/arztebl.m2022.0122_ref41","unstructured":"Europ\u00e4ische Beobachtungsstelle f\u00fcr Drogen und Drogensucht (EBDD). Europ\u00e4ischer Drogenbericht: Trends und Entwicklungen. Lissabon, 2019."},{"key":"10.3238\/arztebl.m2022.0122_ref42","doi-asserted-by":"crossref","unstructured":"Wittchen HU, Behrendt S, H\u00f6fler M, et al.: What are the high risk periods for incident substance use and transitions to abuse and dependence? Implications for early intervention and prevention. Int J Methods Psychiatr Res 2008; 17: 16\u201329.","DOI":"10.1002\/mpr.254"},{"key":"10.3238\/arztebl.m2022.0122_ref43","doi-asserted-by":"crossref","unstructured":"Moffitt TE, Arseneault L, Belsky D, et al.: A gradient of childhood self-control predicts health, wealth, and public safety. Proc Natl Acad Sci 2011; 108: 2693\u20138.","DOI":"10.1073\/pnas.1010076108"},{"key":"10.3238\/arztebl.m2022.0122_ref44","doi-asserted-by":"crossref","unstructured":"Moffitt TE, Caspi A: Childhood predictors differentiate life-course persistent and adolescence-limited antisocial pathways among males and females. Dev Psychopathol 2001; 13: 355\u201375.","DOI":"10.1017\/S0954579401002097"},{"key":"10.3238\/arztebl.m2022.0122_ref45","doi-asserted-by":"crossref","unstructured":"K\u00fcfner H: Psychologische Grundlagen der Sucht. In: Soyka M, Batra A, Heinz A, Moggi F (eds.): Suchtmedizin. M\u00fcnchen: Elsevier 2019: 35\u201366.","DOI":"10.1016\/B978-3-437-23021-9.00004-7"},{"key":"10.3238\/arztebl.m2022.0122_ref46","doi-asserted-by":"crossref","unstructured":"Ross EJ, Graham DL, Money KM, Stanwood GD: Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Neuropsychopharmacology 2015; 40: 61\u201387.","DOI":"10.1038\/npp.2014.147"},{"key":"10.3238\/arztebl.m2022.0122_ref47","doi-asserted-by":"crossref","unstructured":"Lopez-Quintero C, P\u00e9rez de los Cobos J, Hasin DS, et al.: Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend 2011; 115: 120\u201330.","DOI":"10.1016\/j.drugalcdep.2010.11.004"},{"key":"10.3238\/arztebl.m2022.0122_ref48","doi-asserted-by":"crossref","unstructured":"Lorenzetti V, Hoch E, Hall W: Adolescent cannabis use, cognition, brain health and educational outcomes: a review of the evidence. Eur Neuropsychopharmacol 2020; 36: 169\u201380.","DOI":"10.1016\/j.euroneuro.2020.03.012"},{"key":"10.3238\/arztebl.m2022.0122_ref49","doi-asserted-by":"crossref","unstructured":"Moore TH, Zammit S, Lingford-Hughes A, et al.: Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319\u201328.","DOI":"10.1016\/S0140-6736(07)61162-3"},{"key":"10.3238\/arztebl.m2022.0122_ref50","doi-asserted-by":"crossref","unstructured":"Gibbs M, Winsper C, Marwaha S, Gilbert E, Broome M, Singh SP: Cannabis use and mania symptoms: a systematic review and meta-analysis. J Affect Disord 2015; 171: 39\u201347.","DOI":"10.1016\/j.jad.2014.09.016"},{"key":"10.3238\/arztebl.m2022.0122_ref51","doi-asserted-by":"crossref","unstructured":"Degenhardt L, Coffey C, Romaniuk H, Swift W, Carlin JB, Patton GC: The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood. Addiction 2013; 108: 124\u201333.","DOI":"10.1111\/j.1360-0443.2012.04015.x"},{"key":"10.3238\/arztebl.m2022.0122_ref52","doi-asserted-by":"crossref","unstructured":"Gobbi G, Atkin T, Zytynski T, et al.: Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis. JAMA Psychiatry 2019; 76: 426\u201334.","DOI":"10.1001\/jamapsychiatry.2018.4500"},{"key":"10.3238\/arztebl.m2022.0122_ref53","doi-asserted-by":"crossref","unstructured":"Hall W, Degenhardt L: The adverse effects of chronic cannabis use. Drug Test Analysis 2014; 6: 39\u201345.","DOI":"10.1002\/dta.1506"},{"key":"10.3238\/arztebl.m2022.0122_ref54","doi-asserted-by":"crossref","unstructured":"Fergusson DM, Lynskey MT, Horwood LJ: The short-term consequences of early onset cannabis use. J Abnorm Child Psychol 1996; 24: 499\u2013512.","DOI":"10.1007\/BF01441571"},{"key":"10.3238\/arztebl.m2022.0122_ref55","doi-asserted-by":"crossref","unstructured":"Horwood LJ, Fergusson DM, Hayatbakhsh MR, et al.: Cannabis use and educational achievement: findings from three Australasian cohort studies. Drug Alcohol Depend 2010; 110: 247\u201353.","DOI":"10.1016\/j.drugalcdep.2010.03.008"},{"key":"10.3238\/arztebl.m2022.0122_ref56","doi-asserted-by":"crossref","unstructured":"Sch\u00e4fer I, Pawils S, Driessen M, et al.: Understanding the role of childhood abuse and neglect as a cause and consequence of substance abuse: the German CANSAS-Network. Europ J Psychotraumatology 2017; 8: 1304114.","DOI":"10.1080\/20008198.2017.1304114"},{"key":"10.3238\/arztebl.m2022.0122_ref57","doi-asserted-by":"crossref","unstructured":"AACAP Official Action Bukstein OG, Bernet W, Arnold V,et al.: Practice parameter for the assessment and treatment of children and adolescents with substance use disorder. J Am Acad Child Adolesc Psychiatry 2005; 44: 609\u201321.","DOI":"10.1097\/01.chi.0000159135.33706.37"},{"key":"10.3238\/arztebl.m2022.0122_ref58","doi-asserted-by":"crossref","unstructured":"Cabanisa M, Outadib A, Choib F: Early childhood trauma, substance use and complex concurrent disorders among adolescents. Curr Opin Psychiatry 2021; 34: 393\u20139.","DOI":"10.1097\/YCO.0000000000000718"},{"key":"10.3238\/arztebl.m2022.0122_ref59","unstructured":"Thomasius R, Geyer D, Vogt I, et al.: Behandlung alkoholbezogener St\u00f6rungen bei Kindern und Jugendlichen: Altersspezifische Empfehlungen der AWMF-S3-Leitlinie. Alkoholbezogene St\u00f6rungen 2021. www.awmf.org\/uploads\/tx_szleitlinien\/076-001k_S3-Screening-Diagnose-Behandlung-alkoholbezogene-Stoerungen_2021-02.pdf (last accessed on 7 May 2021)."},{"key":"10.3238\/arztebl.m2022.0122_ref60","unstructured":"Baving L, Bilke O: Psychische und Verhaltensst\u00f6rungen durch psychotrope Substanzen. In: Deutsche Gesellschaft f\u00fcr Kinder- und Jugendpsychiatrie und Psychotherapie, Bundesarbeitsgemeinschaft Leitender Klinik\u00e4rzte, Berufsverband der \u00c4rzte f\u00fcr Kinder- und Jugendpsychiatrie und Psychotherapie (eds.): Leitlinien zur Diagnostik und Therapie von psychischen St\u00f6rungen im S\u00e4uglings-, Kindes- und Jugendalter. K\u00f6ln: Deutscher \u00c4rzte-Verlag 2007: 13\u201333."},{"key":"10.3238\/arztebl.m2022.0122_ref61","unstructured":"Thomasius R, Bilke-Hentsch O, Geyer D, et al.: Alters- und geschlechtsspezifische Populationen. In: Mann K, Hoch E, Batra A (eds.): S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener St\u00f6rungen. Berlin: Springer 2016: 128\u20139."},{"key":"10.3238\/arztebl.m2022.0122_ref62","unstructured":"Thoms E, Thomasius R, Holtmann M, et al.: Handreichung zur Behandlung stoffgebundener Suchterkrankungen in der kinder- und jugendpsychiatrischen und -psychotherapeutischen Praxis. Forum f\u00fcr Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie 2019; 4: 21\u201341."},{"key":"10.3238\/arztebl.m2022.0122_ref63","doi-asserted-by":"crossref","unstructured":"Williams RJ, Chang SY, Addiction Center Adolescent Research Group: A comprehensive and comparative review of adolescent substance abuse treatment outcome. Clin Psychol 2000; 7: 138\u201366.","DOI":"10.1093\/clipsy.7.2.138"},{"key":"10.3238\/arztebl.m2022.0122_ref64","doi-asserted-by":"crossref","unstructured":"Hogue A, Henderson CE, Becker SJ, Knight DK: Evidence base on outpatient behavioral treatments for adolescent substance use, 2014\u20132017: outcomes, treatment delivery, and promising horizons. J Clin Child Adolesc Psychol 2018; 47: 499\u2013526.","DOI":"10.1080\/15374416.2018.1466307"},{"key":"10.3238\/arztebl.m2022.0122_ref65","doi-asserted-by":"crossref","unstructured":"Hogue A, Henderson CE, Ozechowski TJ, Robbins MS: Evidence base on outpatient behavioral treatments for adolescent substance use: updates and recommendations 2007\u20132013. J Clin Child Adolesc Psychol 2014; 43: 697\u2013720.","DOI":"10.1080\/15374416.2014.915550"},{"key":"10.3238\/arztebl.m2022.0122_ref66","unstructured":"Thomasius R, Heinz A, Detert S, Arnaud N: Pr\u00e4vention von Alkohol- und Drogenabh\u00e4ngigkeit. In: Klosterk\u00f6tter J, Maier W (eds.): Handbuch pr\u00e4ventive Psychiatrie: Forschung \u2013 Lehre \u2013 Versorgung. 1 Auflage. Stuttgart: Schattauer 2017; 285\u2013318."},{"key":"10.3238\/arztebl.m2022.0122_ref67","doi-asserted-by":"crossref","unstructured":"Stolle M, Sack PM, Thomasius R: Binge drinking in childhood and adolescence: epidemiology, consequences, and interventions. Dtsch Arztebl Int 2009; 106: 323\u20138.","DOI":"10.3238\/arztebl.2009.0323"},{"key":"10.3238\/arztebl.m2022.0122_ref68","doi-asserted-by":"crossref","unstructured":"Bachrach RL, Chung T: Moderators of substance use disorder treatment for adolescents. J Clin Child Adolesc Psychol 2021; 50: 498\u2013509.","DOI":"10.1080\/15374416.2020.1790379"},{"key":"10.3238\/arztebl.m2022.0122_ref69","unstructured":"Laging M: Assessment und Diagnostik in der sekund\u00e4ren Suchtpr\u00e4vention bei Jugendlichen. Pr\u00e4vention 2005; 1: 9\u201312."},{"key":"10.3238\/arztebl.m2022.0122_ref70","unstructured":"Behavioral health trends in the United States: results from the 2014 national survey on drug use and health (HHS Publication No. SMA 15\u20134927, NSDUH Series H-50). Rockville, MD: Substance Abuse and Mental Health Services Administration 2015."},{"key":"10.3238\/arztebl.m2022.0122_ref71","unstructured":"Sack PM, Kr\u00fcger A: St\u00f6rungsspezifische diagnostische Verfahren. In: Thomasius R, Schulte-Markwort M, K\u00fcstner UJ, Riedesser P (eds.): Handbuch der Suchtst\u00f6rungen im Kindes- und Jugendalter. Stuttgart: Schattauer 2009."},{"key":"10.3238\/arztebl.m2022.0122_ref72","doi-asserted-by":"crossref","unstructured":"Thomasius R: Suchttherapie. In: Hoffmann GF, Lentze MJ, Spranger J, et al. (eds.): P\u00e4diatrie. Grundlagen und Praxis. Band 2, 5. edition. Berlin: Springer 2020; 2755\u20137.","DOI":"10.1007\/978-3-662-60300-0_287"},{"key":"10.3238\/arztebl.m2022.0122_ref73","doi-asserted-by":"crossref","unstructured":"Lees R, Hines LA, D\u2019Souza DC, et al.: Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review. Psychol Med 2021; 51: 353\u201364.","DOI":"10.1017\/S0033291720005449"},{"key":"10.3238\/arztebl.m2022.0122_ref74","doi-asserted-by":"crossref","unstructured":"Lu W, Mu\u00f1oz-Laboy M, Sohler M, Goodwin RD: Trends and disparities in treatment for co-occurring major depression and substance use disorders among US adolescents from 2011 to 2019. JAMA Network Open 2021; 4: e2130280.","DOI":"10.1001\/jamanetworkopen.2021.30280"},{"key":"10.3238\/arztebl.m2022.0122_ref75","doi-asserted-by":"crossref","unstructured":"Friedman AS, Glickman NW: Program characteristics that predect to successful treatment of adolescent drug abuse. J Nerv Ment Dis 1986; 174: 669\u201379.","DOI":"10.1097\/00005053-198611000-00006"},{"key":"10.3238\/arztebl.m2022.0122_ref76","doi-asserted-by":"crossref","unstructured":"Kaminer Y: Clinical implications of the relationship between attention deficit hyperactivity disorder and psychoactive substance use disorders. Am J Addict 1992; 1: 257\u201364.","DOI":"10.3109\/10550499209004028"},{"key":"10.3238\/arztebl.m2022.0122_ref77","unstructured":"Deutsche Gesellschaft f\u00fcr Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde, Deutsche Gesellschaft f\u00fcr Suchtforschung und Suchttherapie (eds.): S3 Leitlinie Screening, Diagnose und Behandlung alkoholbezogener St\u00f6rungen. AWMF-Register Nr. 076\u2013001. www.awmf.org\/uploads\/tx_szleitlinien\/076-001l_S3-Screening-Diagnose-Behandlung-alkoholbezogene-Stoerungen_2021-02.pdf (last accessed on 20 Januar 2022)."},{"key":"10.3238\/arztebl.m2022.0122_ref78","unstructured":"Deutsche Hauptstelle f\u00fcr Suchtfragen. Die Versorgung von Menschen mit Suchtproblemen in Deutschland. Analysen der Hilfen und Angebote & Zukunftsperspektiven. Update 2019. www.dhs.de\/fileadmin\/user_upload\/pdf\/suchthilfe\/Versorgungssystem\/Die_Versorgung_Suchtkranker_in_Deutschland_Update_2019.pdf (last accessed on 20 Januar 2022)"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T06:49:51Z","timestamp":1655189391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2022.0122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":78,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2022.0122","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]}}}